| 8:00 a.m. | Registration and Light Refreshments |
| 8:30 a.m. | Introductions Sheila Taube, Ph.D., National Cancer Institute |
| 8:45 a.m. | Embedding and Evaluating Endpoints in Prostate Cancer Trials
Prostate 101+: Disease States, Treatment Issues, and the Use of PSA Endpoints Endpoint Definitions Overview of FDA Workshops and Issues Review of NCI Trials: Opportunities for Endpoint Studies |
| 11:00 a.m. | Discussion |
| 12:30 p.m. | Lunch |
| 1:15 p.m. | NCI Updates |
| 1:45 p.m. | TAILORx (PACCT-1) Trial |
| 2:15 p.m. | Colon Studies Update |
| 2:45 p.m. | Lung Studies Update |
| 3:15 p.m. | Adjourn |
